Polycythemia vera (PV) is a chronic blood cancer classified among myeloproliferative neoplasms, where the marrow produces excess red blood cells. The condition raises the risk of clotting and can affect daily activities long after diagnosis.
Managing Blood Counts and Ongoing Symptoms
Physicians aim to keep the hematocrit under 45% to lower clot risk, according to Neil Dunavin, MD, MS of City of Hope Cancer Center Chicago. He explained that this target is a core part of PV care.
Even when lab values stay within target, many patients still report fatigue, itching, or headaches. Dr. Dunavin noted that fatigue may stem from lingering inflammation, iron loss due to phlebotomy, or unrelated issues such as sleep disturbances or thyroid problems.
Initial therapy typically combines therapeutic phlebotomy with a daily low-dose aspirin (81 mg), as described by Adeel Khan, MD, MPH, MS of UT Southwestern Medical Center. Phlebotomy removes a set volume of blood to reduce red cell mass, while aspirin helps prevent clot formation.
Some individuals continue to experience a cluster of symptoms despite normalized counts. Reported problems include persistent fatigue, intense itching after water exposure (aquagenic pruritus), headaches, dizziness, burning pain in the extremities (erythromelalgia), and an enlarged spleen.
Aquagenic pruritus is triggered by warm water and is linked to abnormal JAK2 signaling, which makes skin mast cells and basophils more reactive, Dr. Dunavin said. The reaction releases histamine and other itch-inducing substances, often without a visible rash.
Patients can lessen itching by taking shorter, cooler showers, applying moisturizer while the skin is still damp, and using antihistamines or prescribed anti-itch creams. In some cases, phototherapy is considered, and controlling the underlying disease may also reduce episodes.
Practical Guidance for Travel and Daily Monitoring
Because PV raises clot risk, long periods of immobility—such as during flights or desk work—require extra caution. Dr. Khan advises staying hydrated, standing or walking regularly, performing calf-raise exercises, and considering graduated compression stockings after consulting a care team.
For symptom tracking, many patients use a simple notebook or the Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF). The checklist prompts users to record fatigue, itching, headaches, vision changes, dizziness, extremity pain, bone discomfort, night sweats, abdominal fullness, and concentration difficulties.
Doctors suggest also noting the dates of phlebotomy sessions, how patients feel during and after each procedure, any iron-related symptoms, and whether the hematocrit remains within the target range.
Treatment plans may shift if symptoms worsen, if the hematocrit repeatedly exceeds 45%, if phlebotomies become frequent or intolerable, if white-blood-cell or platelet counts rise, if the spleen enlarges, or if unusual bleeding or clotting events occur. In such cases, clinicians may add cytoreductive drugs like hydroxyurea.
Patients should contact their physician promptly for any new or escalating issues, even when recent labs look normal. Dr. Dunavin said patients should report unexplained bleeding, worsening headaches or vision changes, fevers, night sweats, left-rib pain, unexpected weight loss, medication intolerance, or sudden neurological signs such as weakness, numbness, speech difficulty, or vision loss.
Adjusting Therapy Beyond Phlebotomy
Monitoring the response to therapy involves regular laboratory checks and symptom logs. Adjustments may be required if side effects appear or if blood counts fail to stay within desired limits.
Additional symptom-focused options are evaluated if itching, pain, or fatigue persist despite the current regimen. Physicians may explore topical agents, antihistamines, or other supportive measures tailored to each individual’s experience.
When to Seek Immediate Care
Sudden neurological changes such as weakness, numbness, difficulty speaking, or loss of vision demand urgent evaluation, as they can signal a clot or bleeding event.
Prompt attention is also essential for chest discomfort, shortness of breath, or a painful, swollen leg, all of which may indicate a serious vascular complication.
High-altitude travel adds another layer of risk; lower oxygen levels can increase clotting potential, so patients should discuss preventive strategies with their care team before embarking.
Compression stockings and, in select high-risk cases, prophylactic anticoagulants may be recommended to further reduce clot formation during prolonged immobility.
